
Zig Therapeutics is a TechBio company pioneering personalized medicine through intelligent drug and nutrition solutions. They develop closed-loop clinical care systems utilizing AI, machine learning, multi-modal digital biomarkers, and novel drug delivery devices. Their approach focuses on adapting treatments in real-time, integrating genetics with predictive intelligence, and tailoring therapies to individual needs. Zig Therapeutics aims to reduce inefficiencies, lower healthcare delivery costs, and improve alignment across the value chain by transforming the home into a healthcare hub. They operate as a combination product, Software as a Medical Device (SaMD), and medical device company, regulated by the FDA and other global agencies.

Zig Therapeutics is a TechBio company pioneering personalized medicine through intelligent drug and nutrition solutions. They develop closed-loop clinical care systems utilizing AI, machine learning, multi-modal digital biomarkers, and novel drug delivery devices. Their approach focuses on adapting treatments in real-time, integrating genetics with predictive intelligence, and tailoring therapies to individual needs. Zig Therapeutics aims to reduce inefficiencies, lower healthcare delivery costs, and improve alignment across the value chain by transforming the home into a healthcare hub. They operate as a combination product, Software as a Medical Device (SaMD), and medical device company, regulated by the FDA and other global agencies.